TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4.Key Insights 4.1 Prevalence Of Diabetes, 2018, Key Countries/ Region 4.2 Technological Advancements 4.3 Pricing Analysis, Key Regions/Key Players 4.4 Recent Industry Developments Such As Mergers & Acquisitions 5. Global Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast– By Product 5.2.1 Monitoring Devices 5.2.1.1 Blood Glucose Meters 5.2.1.2 Test Strips 5.2.1.3 Lancets 5.2.1.4 Others 5.2.2 Treatment Devices 5.2.2.1 Insulin Pens 5.2.2.2 Insulin Pumps 5.2.2.3 Insulin Syringes 5.2.2.4 Insulin Jet Injectors 5.2.2.5 Others 5.3. Market Analysis, Insights and Forecast– By Distribution Channel 5.3.1 Institutional Sales 5.3.1.1 Hospitals 5.3.1.2 Clinics 5.3.1.3 Others 5.3.2 Retail Sales 5.3.2.1 Hospital Pharmacies 5.3.2.2 Retail Pharmacies 5.3.2.3 Online Pharmacies 5.4. Market Analysis, Insights and Forecast– By Region 5.4.1 North America 5.4.2 Europe 5.4.3 Asia Pacific 5.4.4 Latin America 5.4.5 Middle East & Africa 6. North America Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis, Insights and Forecast – By Product 6.2.1 Monitoring Devices 6.2.1.1 Blood Glucose Meters 6.2.1.2 Test Strips 6.2.1.3 Lancets 6.2.1.4 Others 6.2.2 Treatment Devices 6.2.2.1 Insulin Pens 6.2.2.2 Insulin Pumps 6.2.2.3 Insulin Syringes 6.2.2.4 Insulin Jet Injectors 6.2.2.5 Others 6.3. Market Analysis, Insights and Forecast – By Distribution Channel 6.3.1 Institutional Sales 6.3.1.1 Hospitals 6.3.1.2 Clinics 6.3.1.3 Others 6.3.2 Retail Sales 6.3.2.1 Hospital Pharmacies 6.3.2.2 Retail Pharmacies 6.3.2.3 Online Pharmacies 6.4. Market Analysis, Insights and Forecast – By Country 6.4.1 U.S. 6.4.2 Canada 7. Europe Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis, Insights and Forecast – By Product 7.2.1 Monitoring Devices 7.2.1.1 Blood Glucose Meters 7.2.1.2 Test Strips 7.2.1.3 Lancets 7.2.1.4 Others 7.2.2 Treatment Devices 7.2.2.1 Insulin Pens 7.2.2.2 Insulin Pumps 7.2.2.3 Insulin Syringes 7.2.2.4 Insulin Jet Injectors 7.2.2.5 Others 7.3. Market Analysis, Insights and Forecast – By Distribution Channel 7.3.1 Institutional Sales 7.3.1.1 Hospitals 7.3.1.2 Clinics 7.3.1.3 Others 7.3.2 Retail Sales 7.3.2.1 Hospital Pharmacies 7.3.2.2 Retail Pharmacies 7.3.2.3 Online Pharmacies 7.4. Market Analysis, Insights and Forecast – By Country/Sub-region 7.4.1 U.K. 7.4.2 Germany 7.4.3 Spain 7.4.4 Itlay 7.4.5 Scandinavia 7.4.6 France 7.4.7 Rest of Europe 8.Asia Pacific Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis, Insights and Forecast – By Product 8.2.1 Monitoring Devices 8.2.1.1 Blood Glucose Meters 8.2.1.2 Test Strips 8.2.1.3 Lancets 8.2.1.4 Others 8.2.2 Treatment Devices 8.2.2.1 Insulin Pens 8.2.2.2 Insulin Pumps 8.2.2.3 Insulin Syringes 8.2.2.4 Insulin Jet Injectors 8.2.2.5 Others 8.3. Market Analysis, Insights and Forecast – By Distribution Channel 8.3.1 Institutional Sales 8.3.1.1 Hospitals 8.3.1.2 Clinics 8.3.1.3 Others 8.3.2 Retail Sales 8.3.2.1 Hospital Pharmacies 8.3.2.2 Retail Pharmacies 8.3.2.3 Online Pharmacies 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region 8.4.1 China 8.4.2 India 8.4.3 Australia 8.4.4 Japan 8.4.5 Southeast Asia 8.4.6 Rest of Asia Pacific 9. Latin America Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis, Insights and Forecast – By Product 9.2.1 Monitoring Devices 9.2.1.1 Blood Glucose Meters 9.2.1.2 Test Strips 9.2.1.3 Lancets 9.2.1.4 Others 9.2.2 Treatment Devices 9.2.2.1 Insulin Pens 9.2.2.2 Insulin Pumps 9.2.2.3 Insulin Syringes 9.2.2.4 Insulin Jet Injectors 9.2.2.5 Others 9.3. Market Analysis, Insights and Forecast – By Distribution Channel 9.3.1 Institutional Sales 9.3.1.1 Hospitals 9.3.1.2 Clinics 9.3.1.3 Others 9.3.2 Retail Sales 9.3.2.1 Hospital Pharmacies 9.3.2.2 Retail Pharmacies 9.3.2.3 Online Pharmacies 9.4. Market Analysis, Insights and Forecast – By Country/Sub-region 9.4.1 Brazil 9.4.2 Mexico 9.4.3 Rest of Latin America 10. Middle East & Africa Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026 10.1. Key Findings / Summary 10.2. Market Analysis, Insights and Forecast – By Product 10.2.1 Monitoring Devices 10.2.1.1 Blood Glucose Meters 10.2.1.2 Test Strips 10.2.1.3 Lancets 10.2.1.4 Others 10.2.2 Treatment Devices 10.2.2.1 Insulin Pens 10.2.2.2 Insulin Pumps 10.2.2.3 Insulin Syringes 10.2.2.4 Insulin Jet Injectors 10.2.2.5 Others 10.3. Market Analysis, Insights and Forecast – By Distribution Channel 10.3.1 Institutional Sales 10.3.1.1 Hospitals 10.3.1.2 Clinics 10.3.1.3 Others 10.3.2 Retail Sales 10.3.2.1 Hospital Pharmacies 10.3.2.2 Retail Pharmacies 10.3.2.3 Online Pharmacies 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region 10.4.1 South Africa 10.4.2 GCC 10.4.3 Rest of Middle East and Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2018) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability)) 11.5.1 F. Hoffmann-La Roche Ltd. 11.5.2 Tandem Diabetes Care, Inc. 11.5.3 B. Braun Melsungen AG 11.5.4 PHC Holdings Corporation 11.5.5 Medtronic 11.5.6 BD 11.5.7 Novo Nordisk A/S 11.5.8 Abbott 11.5.9 Other Prominent Players 12. Strategic Recommendations

Hoffmann-La Roche Ltd Tandem Diabetes Care, Inc. Braun Melsungen AG PHC Holdings Corporation Medtronic BD Novo Nordisk A/S Abbott Sanofi Other players